1. Home
  2. HTLD vs MNKD Comparison

HTLD vs MNKD Comparison

Compare HTLD & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heartland Express Inc.

HTLD

Heartland Express Inc.

HOLD

Current Price

$14.28

Market Cap

738.1M

Sector

Industrials

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$3.30

Market Cap

877.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTLD
MNKD
Founded
1978
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.1M
877.0M
IPO Year
1995
2004

Fundamental Metrics

Financial Performance
Metric
HTLD
MNKD
Price
$14.28
$3.30
Analyst Decision
Hold
Buy
Analyst Count
6
8
Target Price
$11.50
$8.69
AVG Volume (30 Days)
505.5K
6.0M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
0.60%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$805,709,000.00
$348,966,000.00
Revenue This Year
N/A
$35.81
Revenue Next Year
$8.36
$11.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.23
52 Week Low
$7.00
$2.23
52 Week High
$14.27
$6.51

Technical Indicators

Market Signals
Indicator
HTLD
MNKD
Relative Strength Index (RSI) 70.34 58.69
Support Level $12.23 $2.45
Resistance Level N/A $6.08
Average True Range (ATR) 0.52 0.26
MACD 0.07 -0.00
Stochastic Oscillator 100.00 34.11

Price Performance

Historical Comparison
HTLD
MNKD

About HTLD Heartland Express Inc.

Heartland Express Inc, along with its subsidiaries, operates as a short, medium, and long-haul truckload carrier and transportation services provider. It mainly provides nationwide asset-based dry van truckload service for shippers across the United States, along with cross-border freight and other transportation services offered through third-party partnerships in Mexico. The group operates under the brand names of Heartland Express, Millis Transfer, Smith Transport, and CFI (for services within Mexico).

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: